Official EU label nameGlossary entry 29690

URIDINE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:58-96-8

EC:200-407-5

Ingredient index records:

URIDINE

Cosmetic functions: SKIN CONDITIONING, SKIN PROTECTING

1-beta-D-Ribofuranosyluracil

Open full local profile

1 matched or reported name

URIDINE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name URIDINE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 58-96-8

CAS 58-96-8PubChem CID 6029

Uridine

Uridine is a ribonucleoside composed of a molecule of uracil attached to a ribofuranose moiety via a betaN1-glycosidic bond. It has a role as a drug metabolite, a human metabolite and a fundamental metabolite. It is functionally related to a uracil. — ChEBI

IUPAC name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

Molecular formula: C9H12N2O6
Molecular weight: 244.20 g/mol
Exact mass: 244.06953611 Da
XLogP3: -2.0
Topological polar surface area: 119.0 Å²
Hydrogen-bond donors: 4
Hydrogen-bond acceptors: 6
Covalent units: 1
Defined stereocentres: 4

Also known as

UridinUracil riboside1-beta-D-RibofuranosyluracilCHEBI:16704WHI7HQ7H85NSC-202561-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione

16 more reported names

Allo UridineAllo-Uridine1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidine-2,4-dione1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dioneRefChem:6340200-407-5Uracil, 1-beta-D-ribofuranosyl-beta-Uridine1-.beta.-D-Ribofuranosyluracild-Ribosyl uracilAI3-526901-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dioneNSC 20256URIDINE [MART.]Urd1-A-D-Ribofuranosyluracil

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:16704
ChEMBL:CHEMBL100259
EPA DTXSID:DTXSID40891555
PubMed:37659621
PubMed:27469509
PubMed:27374097
PubMed:24709313
PubMed:23113246
PubMed:23104528
PubMed:23073584
PubMed:23037308
PubMed:23001034
PubMed:22994488
PubMed:22993689
PubMed:22988838

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision